Lupus Trials News

The best and brightest are working toward finding better treatments and ultimately a cure for lupus. Read about how the most important influencers in the lupus community are effecting lupus research, along with other issues that matter most to you.

Study Finds Booster Vaccine Significantly Lowered COVID-19 Infection Risk Among People with Lupus

July 14, 2022 The booster dose of the SARS-CoV-2 vaccine significantly enhanced  the degree of protection from COVID-19 infections for...

Read More

Lupus Research Alliance and Lupus Therapeutics Response to Positive Data from Phase 2 Study on Potential First-in-class Lupus Treatment

June 1, 2022 The Lupus Research Alliance (LRA) and its clinical trial arm Lupus Therapeutics congratulate Bristol Myers Squibb (BMS)...

Read More

Jane Salmon, MD – Determined to Help Pregnant Women Triumph Over Lupus

March 24, 2022 Recognized for her contributions to lupus during 2022’s Women’s History Month, Dr. Jane Salmon chose to specialize...

Read More

Judith James, MD, PhD Fulfills Childhood Dream to be a Doctor with Outstanding Career in Lupus Treatment and Research

March 14, 2022 Dr. Judith James has wanted to be a doctor since she was four years old. But it...

Read More

Encouraging Results with Obinutuzumab for Lupus Nephritis

February 13, 2022 The LRA is pleased to share a recently published paper reporting that the drug, obinutuzumab, showed positive...

Read More

Baricitinib Development as a Lupus Treatment Discontinued

January 28, 2022 The Lupus Research Alliance is disappointed that the Phase 3 development program of  OLUMIANT® (baricitinib) as a...

Read More

Lupus Research Alliance Launches Two Major Initiatives to Increase Participation of Underrepresented Minorities in Lupus Clinical Trials and Research

January 27, 2022 NEW YORK, NY. January 27 — The Lupus Research Alliance (LRA) and its clinical affiliate Lupus Therapeutics...

Read More

FDA Authorizes Evusheld Emergency Use to Prevent COVID-19 in Immunocompromised Patients

December 9, 2021 People with lupus can be immunocompromised because of the disease itself or medications that suppress the immune...

Read More

Aurinia Announces Positive Long-Term Results on Lupykinis™ for Lupus Nephritis

December 9, 2021 The LRA is pleased to share positive topline three-year efficacy and safety results reported today by Aurinia...

Read More

Promise of Additional Lupus Therapies Highlighted at ACR 2021 Annual Meeting

November 9, 2021 Results of clinical trials testing many existing and potential lupus treatments were highlighted at the American College...

Read More

A “Call to Arms” for the Lupus Community

August 18, 2021 Many lupus patients are at risk for COVID-19 infection because of treatment with corticosteroids and other immunosuppressive...

Read More

Two Studies Show COVID-19 Vaccines are Well-Tolerated Among Lupus Patients

August 12, 2021 In two recent studies, researchers found that the four COVID-19 vaccines are well-tolerated in lupus patients. Given...

Read More

Important Message from CEO Kenneth Farber: U.S. FDA Approves New Lupus Treatment

August 2, 2021 Dear Friend of the Lupus Research Alliance, As we reported this morning, the lupus community has much...

Read More

Lupus Research Alliance Applauds U.S. FDA Approval of AstraZeneca’s anifrolumab-fnia (Saphnelo™) for Systemic Lupus Erythematosus (SLE)

  First in New Class of Drugs in More than a Decade for SLE Targeting Type 1 Interferons NEW YORK,...

Read More

Two New Drugs Receive FDA Approval

May 1, 2021 “This is a historic moment in lupus with two new drug approvals for lupus nephritis just over...

Read More

LRA Writes President Supporting Dr. Janet Woodcock for FDA Commissioner

March 31, 2021 As part of the LRA’s mission to accelerate development and availability of much-needed new diagnostics and treatments...

Read More

LRA Congratulates Equillium on Positive Results of Study of Potential New Lupus Treatment

March 30, 2021 Equillium, Inc. announced positive topline data from the phase 1b EQUALISE study in patients with systemic lupus...

Read More

Join LRA’s Interactive, Virtual Lupus Clinical Trials Fair on April 8th!

Join LRA’s Interactive, Virtual Lupus Clinical Trials Fair on April 8th! ·    Learn more about an upcoming study LRA is doing...

Read More

Helping Overcome Lupus Effects on Mental Health

Updated March 11, 2022 Neuropsychiatric lupus affects 80-90% of people with lupus. In a video series hosted by the Young...

Read More

Lupus Research Alliance Hails Approval of Aurinia’s Lupkynis(TM) (voclosoporin)

First Oral Treatment for Lupus Nephritis; Second Lupus Treatment to Receive FDA Approval in Past Month NEW YORK, NY. January...

Read More

Lupus Expert Dr. Richard Furie Addresses Clinical Trials

June 12, 2019 As reported by The Rheumatologist, Dr. Richard Furie provided his perspective on clinical trials in lupus in...

Positive Early Results for BIIB059 as New Treatment Strategy

March 1, 2019 Proteins of the immune system, known as type I interferons, are responsible in part for manifestations of...

People with Lupus at Higher Risk for Bone Fractures, Study Shows

February 22, 2019 A study published in the peer-reviewed journal Arthritis & Rheumatology found that people with SLE and particularly...

Physical Fitness Associated with Health-related Quality of Life, Study Shows

February 22, 2019 Study results published in the peer-reviewed journal PLOS One showed that elements of physical fitness — muscle...

Study Shows Kidney Transplant Improves Lupus Nephritis Survival

A study just published in Annals of Internal Medicine showed that kidney transplantation reduced deaths due to lupus nephritis— kidney inflammation caused by lupus....

Study shows: Stress, Depression and Pain are Major Contributors to Lupus Fatigue

An observational study published in Lupus of people with lupus found that of six factors,  stress, depression and pain contributed most to...

Existing Asthma Medication Shows Effectiveness for Lupus

A small randomized Phase 1 study published in Arthritis & Rheumatology found that the existing asthma treatment omalizumab (Xolair) may improve lupus...

New Trial Begins to Test Investigational Cenerimod to Treat Lupus

Source: Idorsia LTD Press Release Idorsia Ltd (SIX: IDIA)  announced that the first patient has been enrolled into a multiple-dose study...

Poor Dental Care Associated with Lupus

A study just published in Clinical and Experimental Rheumatologyfound that exposure to periodontal bacteria on the gums around the teeth can...

Association Between Lupus and Cancer

A new analysis published in Arthritis Research & Therapy found that SLE is associated with increased risk of 16 cancers and decreased...